Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kanthi Athreya"'
Autor:
Shigang Xiong, Tanya B. Dorff, Andrew V. Schally, Stephen V. Liu, David I. Quinn, Kanthi Athreya, Susan Groshen, Jürgen Engel, Denice D. Tsao-Wei, Jacek Pinski, Steven S. Yu
Publikováno v:
Clinical Genitourinary Cancer. 15:742-749
Background: The prognosis for patients with castration-resistant prostate cancer (CRPC) remains suboptimal and targeted therapies should be explored. One potential target is the receptor for luteinizing hormone-releasing hormone (LHRH-R), which is hi
Autor:
Kanthi Athreya, Marin F. Xavier
Publikováno v:
Nutrition and Cancer. 69:1099-1104
Several clinical trials have produced conflicting results regarding the benefit of antioxidants in cancer therapy thus questioning the incorporation of these substances in standard treatment regimens. Vitamins E and C, selenium, carotenoids, lycopene
Autor:
Kanthi Athreya, Sonia Ali
Publikováno v:
Translational Cancer Research. 6:30-37
Autor:
Kanthi Athreya Kollengode, Joshua L. Usher, Kathleen D. Danenberg, Jacek Pinski, Peter V. Danenberg, Eric C. Huang, Genevieve Danenberg, Erwin Grussie, Shahrooz Rabizadeh
Publikováno v:
Journal of Clinical Oncology. 36:e17077-e17077
e17077Background: Cell-free circulating RNA (cfRNA) released into the bloodstream by tumors allows non-invasive identification of molecular changes via the quantity of particular genes (i.e., gene ...
Autor:
Alan L. Epstein, Ali Rafatnia, Arnab Basu, Genevieve Danenberg, Jacek Pinski, Eesha Chakravartty, Kanthi Athreya Kollengode, Hugh Manoli
Publikováno v:
Journal of Clinical Oncology. 36:338-338
338 Background: Human Myeloid Derived Suppressor Cells (MDSCs) have gained recognition as a significant population of cells that arise in cancer patients to mediate immune tolerance. MDSCs have been validated as a prognostic factor in several tumor t
Autor:
Alan L. Epstein, Ali Rafatnia, Kanthi Athreya Kollengode, Hugh Manoli, Arnab Basu, Genevieve Danenberg, Jacek Pinski, Eesha Chakravartty
Publikováno v:
Journal of Clinical Oncology. 36:TPS713-TPS713
TPS713 Background: Human Myeloid Derived Suppressor Cells (MDSCs) have gained recognition as a significant population of cells that arise in cancer patients to mediate immune tolerance. Some studies have shown MDSC concentrations to be associated wit
Autor:
Genevieve Danenberg, Kathleen D. Danenberg, Peter V. Danenberg, Joshua L. Usher, Kanthi Athreya Kollengode, Jacek Pinski, Erwin Grussie
Publikováno v:
Journal of Clinical Oncology. 36:380-380
380 Background: Recent studies have identified panels of immune-related genes linked to progression and survival. Expressions usually are measured using RNA from tissue samples. The aim of the present study was to utilize circulating RNA (cfRNA) isol
Autor:
Steven S. Yu, David I. Quinn, Andrew V. Schally, Kanthi Athreya, Jürgen Engel, Denice D. Tsao-Wei, Jacek Pinski, Susan Groshen, Stephen V. Liu, Tanya B. Dorff, Shigang Xiong
Publikováno v:
Journal of Clinical Oncology. 35:210-210
210 Background: Luteinizing hormone-releasing hormone receptors (LHRH-R) are expressed in ~86% of prostate cancers, with sustained expression despite prolonged exposure to LHRH agonists. Limited expression of LHRH-R on normal cells suggests LHRH-R ma
Autor:
Kanthi Athreya, Sadanand Vodala, Kathleen D. Danenberg, Mai Dang, Joshua L. Usher, David Samberg, Toshiyuki Ishiba, Todd Sturdevant, Jacek Pinski
Publikováno v:
Journal of Clinical Oncology. 34:e16613-e16613
e16613Background: In prostate cancer (PC), the androgen-receptor isoform that is encoded by the splice variant 7 (AR-V7) is characterized by an absence of the ligand-binding domain that is the targ...
Autor:
Kanthi Athreya, Jacek Pinski, Shigang Xiong, Tanya B. Dorff, Stephen V. Liu, David I. Quinn, S. Yu, Susan Groshen, T.W. Denice, Andrew V. Schally
Publikováno v:
European Journal of Cancer. 51:S488